Amniotics AB

FSX : 66J

Amniotics AB (publ) develops stem cell-based therapeutics to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; CutiStem for the treatment of dermatological indications; and AMNI-NK003. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.

Information

Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
Sweden

Price

EUR 0.00

Symbol

66J

Type

Common Stock

Previous Close

:

0.00

52 Week Range

:

0.00 - 0.00

Volume

:

1,000,000.00

Average Volume

:

615,000.00

High

:

0.00

Low

:

0.00

Change

:

0.00

Percent change (%)

:

0.00

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...